J. Alex Hammond - Concepedia

Author

J. Alex Hammond

Also Known As

J Alex Hammond, J. Alex Hammond, J.A Hammond, J.A. Hammond, J.Alex Hammond, James A Hammond, James A. Hammond, James Hammond, Jason Hammond

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Toronto Western University London Health Sciences Centre University Health Network Cancer Care Ontario

About

J. Alex Hammond is an author at University of Toronto specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	929
2	Health Sciences	3	3	222
3	Head And Neck Surgery	2	2	170
4	Public Health	1	1	60
5	Biostatistics	1	1	30

J. Alex Hammond

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial Anthony C. Nichols, Julie Theurer, Eitan Prisman, The Lancet Oncology Surgical OncologyRadiation TherapyNeck DissectionMedicineHead And Neck Cancer	2019	445
Early-stage squamous cell carcinoma of the oropharynx: Radiotherapy vs. Trans-Oral Robotic Surgery (ORATOR) – study protocol for a randomized phase II trial Anthony C. Nichols, John Yoo, J. Alex Hammond, BMC Cancer Surgical OncologyCancer ManagementSurgeryTrans-oral Robotic SurgeryOral Cancer	2013	140
Management and Outcome Differences in Supraglottic Cancer Between Ontario, Canada, and the Surveillance, Epidemiology, and End Results Areas of the United States Patti A. Groome, Brian O’Sullivan, Jonathan C. Irish, Journal of Clinical Oncology	2003	112
The Epidemic of Human Papillomavirus and Oropharyngeal Cancer in a Canadian Population Anthony C. Nichols, David A. Palma, Sandeep Dhaliwal, Current Oncology	2013	102
Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma David A. Palma, Eitan Prisman, Eric Berthelet, JAMA Oncology	2022	90
Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules Patti A. Groome, Brian O’Sullivan, William J. Mackillop, International Journal of Radiation OncologyBiologyPhysics MedicineCompromised Local ControlCancer ManagementIntensified Treatment SchedulesTreatment Planning	2006	77
Optimization of high-dose-rate cervix brachytherapy applicator placement: The benefits of intraoperative ultrasound guidance Melanie Davidson, Jasper Yuen, David D’Souza, Brachytherapy Medical UltrasoundSurgical OncologyMedical ImagingMinimally Invasive ProcedureBrachytherapy	2008	71
Does HPV type affect outcome in oropharyngeal cancer? Anthony C. Nichols, Sandeep Dhaliwal, David A. Palma, Journal of Otolaryngology - Head and Neck Surgery	2013	67
Explaining Socioeconomic Status Effects in Laryngeal Cancer Patti A. Groome, Karleen Schulze, Simone Keller, Clinical Oncology Cancer EpidemiologySocioeconomic Status EffectsEpidemiology Of CancerSociologyHealth Disparities	2006	60
Glottic cancer in Ontario, Canada and the SEER areas of the United States Patti A. Groome, Brian O’Sullivan, Jonathan C. Irish, Journal of Clinical Epidemiology Surgical OncologyTumoral PathologyCancer EpidemiologyMedicineGlottic Cancer	2001	56

Page 1